Completed
RELEASEReal Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
What is being tested
Data Collection
Who is being recruted
Asthma+6
+ Bronchial Diseases
+ Hypersensitivity
Over 18 Years
+7 Eligibility Criteria
How is the trial designed
Treatment Study
Phase 3
Interventional
Study Start: September 2005
Summary
Principal SponsorAstraZeneca
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: September 1, 2005
Actual date on which the first participant was enrolled.The purpose of this study is to determine whether patients with asthma are better able to manage and control their symptoms by using one inhaler daily that both prevents as well as treats the symptoms of an asthma exacerbation.
Official TitleReal Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
Principal SponsorAstraZeneca
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
550 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
AsthmaBronchial DiseasesHypersensitivityHypersensitivity, ImmediateImmune System DiseasesLung DiseasesLung Diseases, ObstructiveRespiratory HypersensitivityRespiratory Tract Diseases
Criteria
3 inclusion criteria required to participate
Aged over 18
Confirmed diagnosis of mild to moderate asthma by doctor
Currently receiving inhaled corticoid-steroid medicine for treatment of asthma and requiring a review of current asthma treatment
4 exclusion criteria prevent from participating
Women who are pregnant, breast-feeding, or planning pregnancy
Patients with a history of chronic obstructive pulmonary disease
Patients using any beta blocker therapy
Patients receiving steroid tablets or steroid injections
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 59 locations
Suspended
Suspended
Research Site
Hove, United KingdomSuspended
Research Site
Ilford, United KingdomSuspended
Research Site
Glenrothes, United KingdomCompleted59 Study Centers